Mental health issues are common in people with traumatic brain injury (TBI) and can continue for years. They may be related ...

Explore TTUHSC's CAVALIER trial assessing calcium and vasopressin's efficacy in treating traumatic injury patients with blood ...

Researchers at Mass General Brigham found that a nasal spray delivering anti-CD3 (Foralumab) reduces neuroinflammation, ...

Shares of Tiziana Life Sciences (NASDAQ:TLSA) jumped 12% Thursday after the company said that a study of its drug candidate ...

Discover how a novel nasal spray could revolutionize traumatic brain injury treatment by reducing neuroinflammation and ...

A nasal spray being developed to target brain inflammation can also prove effective in treating traumatic brain injury (TBI) ...

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one ...

A team of researchers has developed an advanced physics-based AI-driven tool to aid the forensic investigation of traumatic brain injuries (TBI).

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI).

Lawmakers across the political spectrum have ramped up efforts to understand, prevent and treat traumatic brain injuries, or TBI, among service members and veterans.

This milestone follows the successful IRB approval, pilot testing and evaluation of Nexalin’s Halo technology at UCSD. The study will evaluate Nexalin’s proprietary Deep Intracranial Frequency ...

Tiziana Life Sciences (TLSA) announced the publication of a landmark study in Nature Neuroscience demonstrating that nasal administration of ...